REGULATION OF STEROID HORMONES BY OXIDOREDUCTASES

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$185,910.00
Award Year:
2005
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA113154-01
Award Id:
75563
Agency Tracking Number:
CA113154
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Altoris, Inc., 11575 Sorrento Valley Road, San Diego, CA, 92121
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
HUGO VILLAR
(858) 259-8161
hugo@altoris.com
Business Contact:
(858) 453-9509
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Sex steroids play important roles in a number of cancers including breast, ovarian, endometrial and prostate cancers. In this proposal, we are planning to investigate means to modulate steroid levels in an effort to suppress tumor growth. During the Phase I of this proposal we will design inhibitors for 17beta-dehydrogenase, the enzyme that catalyzes the last step of 17beta-estradiol biosynthesis. There is strong literature evidence that modulation of this biosynthetic pathway is an effective treatment strategy, particularly for estrogen sensitive breast cancers. Small molecule inhibitors will be developed as potential clinical candidates and as biological probes to further study the pharmacological effects of inhibiting enzymes involved in the biosynthesis of 17beta-estradiol, a key steroid involved in the stimulation of breast cancer cell growth. The workplan is composed of four steps: 1) the structure guided design of inhibitors for this enzyme; 2) selection, synthesis and characterization potential inhibitors; 3) enzymological evaluation of the ligands; 4) evaluation of promising inhibitors in cellular assays. During the Phase I we plan to demonstrate that selective inhibitors can be designed for this enzyme using structure guided design starting from the structure of the endogenous ligand. In the process we will generate a small library of compounds that can be used as probes to study their effect on other steroid sensitive cancers. The second phase of these studies will evaluate the compounds in ex-vivo and in-vivo studies, with the ultimate purpose of identifying candidates for drug development.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government